search button
Open Access

Anti‑inflammatory and anti‑apoptosis activity of taraxasterol in ulcerative colitis in vitro and in vivo

  • Authors:
    • Lu Che
    • Ya Li
    • Ruifeng Song
    • Cuihong Qin
    • Weiwei Hao
    • Bingxue Wang
    • Lei Yang
    • Puji Peng
    • Feng Xu

  • View Affiliations

  • Published online on: July 5, 2019     https://doi.org/10.3892/etm.2019.7736
  • Pages: 1745-1751

  • Copyright: © Che et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Ulcerative colitis is closely associated with colorectal cancer, the long‑standing chronic inflammation being the key etiology of ulcerative colitis. The aim of the present study was to identify the anti‑inflammatory and anti‑apoptosis activity of taraxasterol in ulcerative colitis. MTT assay was used to obtain the optimal concentrations of lipopolysaccharide (LPS) and taraxasterol for cell treatments in vitro. A mouse model of colitis was established via dextran sodium sulphate (DSS) administration. Levels of IL‑6 and TNF‑α were detected through ELISA. Flow cytometry and western blotting were used to detect apoptosis and related protein expression levels, respectively. Hematoxylin and eosin staining was performed to detect the pathological damage. The results from the MTT assay identified the optimal concentration of LPS and taraxasterol, and ELISA results demonstrated that taraxasterol treatment decreased the expression levels of IL‑6 and TNF‑α in vitro and in vivo, in a dose‑dependent manner. Taraxasterol treatment inhibited apoptosis, and reduced the protein levels of p53, Bcl‑2 associated X (BAX) and caspase‑3. Finally, pathological damages were reduced in colonic tissues of mice treated with taraxasterol. Taken together, taraxasterol treatment markedly inhibited inflammation and apoptosis in ulcerative colitis. Therefore, taraxasterol may be a promising agent for decreasing the inflammatory response in ulcerative colitis and other inflammation‑related diseases.
View Figures
View References

Related Articles

Journal Cover

September-2019
Volume 18 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.4
  • Ranked Medicine Research and Experimental
    (total number of cites)
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Che L, Li Y, Song R, Qin C, Hao W, Wang B, Yang L, Peng P and Xu F: Anti‑inflammatory and anti‑apoptosis activity of taraxasterol in ulcerative colitis in vitro and in vivo. Exp Ther Med 18: 1745-1751, 2019.
APA
Che, L., Li, Y., Song, R., Qin, C., Hao, W., Wang, B. ... Xu, F. (2019). Anti‑inflammatory and anti‑apoptosis activity of taraxasterol in ulcerative colitis in vitro and in vivo. Experimental and Therapeutic Medicine, 18, 1745-1751. https://doi.org/10.3892/etm.2019.7736
MLA
Che, L., Li, Y., Song, R., Qin, C., Hao, W., Wang, B., Yang, L., Peng, P., Xu, F."Anti‑inflammatory and anti‑apoptosis activity of taraxasterol in ulcerative colitis in vitro and in vivo". Experimental and Therapeutic Medicine 18.3 (2019): 1745-1751.
Chicago
Che, L., Li, Y., Song, R., Qin, C., Hao, W., Wang, B., Yang, L., Peng, P., Xu, F."Anti‑inflammatory and anti‑apoptosis activity of taraxasterol in ulcerative colitis in vitro and in vivo". Experimental and Therapeutic Medicine 18, no. 3 (2019): 1745-1751. https://doi.org/10.3892/etm.2019.7736